MAUI, Hawaii, Nov. 1 /PRNewswire-FirstCall/ --
Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT - News) today announced that it is preparing to launch a national roll-out of its nasal hydration product Flight Spray® to mass market retailers and top-name pharmacy and drug store chains beginning in the first quarter of 2008.
Flight Spray has sold over 50,000 units since its initial launch in April 2005. "We are preparing for a mass market push that has the potential to exponentially increase sales of Flight Spray during 2008," said Steven M. Schorr, chairman & CEO of Bioponic. "The early buzz on Flight Spray was that it was the next Airborne. Good Morning America and ABC Health News were among the first national media outlets to favorably compare it to Airborne. Considering Airborne sold over $100 million last year, Flight Spray could achieve similar sales success given the expansion we have planned in significantly large retail markets."
Flight Spray is currently sold in travel-related retail stores and via web sites such as Magellens.com, TravelSmith.com and Drugstore.com, and on the Company-owned FlightSpray.com. Flight Spray is also available on Amazon.com, along with 85 other Bioponic Phytoceuticals products, and at AllNaturalMerchandise.com. In Australia, Flight Spray is sold on GlobalTravelProducts.com and in the U.K. and Europe at Vocal-care.com. Flight Spray comes in a 1oz. (30ml) and .5oz (15ml) pump spray bottle and is now shelf ready in a display box.
"Flight Spray is a beneficial non-prescription remedy for millions of prospective airline travelers. Our customers rely on Flight Spray to keep them hydrated and healthy during long flights and we are pleased it will soon be available nationwide," added Schorr.
Bioponic Phytoceuticals is engaged in the formulation, production and distribution of natural products for sale in the Complementary Alternative Medicine markets. The Company has developed a new patent pending healing modality "Bioresonant Phytotherapeutics(TM)" and has several branded product lines currently in national distribution. For further information please see www.bioponic.com and www.flightspray.com.
All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control.
CONTACT: Steven M. Schorr, CEO, Bioponic Phytoceuticals, +1-808-876-1711, email@example.com or Geoffrey Eiten, Investor Relations, OTC Financial Network, +1-781-444-6100x613, firstname.lastname@example.org, http://www.otcfn.com/bpyt.